In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Men undergoing androgen deprivation therapy for prostate cancer halve their risk of vertebral fractures if they take the selective estrogen receptor modulator toremifene…
NEW YORK (Reuters Health) – A Canadian study has identified several readily available clinical factors that help determine the risk of fractures in men with prostate cancer undergoing…
A short condensed highlights video covering the three day conference, held in Atlanta, with the theme Convergence: Purpose, Programs & Partners. This conference, now in its fourth year,…
Zachary T. Bloomgarden, MD, Editor of the Journal of Diabetes and a Clinical Professor at the Mount Sinai School of Medicine, provides a critical analysis of the recent…
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses screening of various…
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the use of…
Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the use of…
Victor J. Strecher, PhD, MPH, discusses new technologies and behavior change, as well as how physicians can utilize these new technologies to empower their patients. He also discusses…
NEW YORK (Reuters Health) – Among men who’ve had a negative prostate biopsy, the velocity of increasing prostate specific antigen (PSA) levels is not helpful in deciding whether…
Mark Trahant discusses the transition from traditional mainstream media to social media and its impact on public health messaging, both to the patient and the physician. Mr. Trahant…
